Is Cash Flow a Problem for Aurora Cannabis (TSX:ACB)?

A recent downgrade of Aurora Cannabis stock (TSX:ACB)(NYSE:ACB) has investors worried that the company might be too risky given all the cash it has been burning through.

| More on:

Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) was recently downgraded by an analyst amid fears that the company’s cash burn combined with convertible debt (which is not in the money) due in Q1 could become problematic.

Running low on cash in the industry has, unfortunately, been the norm rather than the exception these days. It’s an important issue and one that I highlighted in the company’s most recent quarterly results.

Let’s take a closer look at how Aurora has done this year to help assess how big of a problem a lack of cash is today.

How much cash is the company burning through?

Over the past nine months, Aurora has used up a combined $324 million to fund both its operating and investing activities. It’s no secret that the company has been recording some significant losses

Although a good chunk of that has related to non-cash items including impairment, the company has also benefitted from fair value gains as well.

One way that Aurora and other pot stocks have been able to alleviate some of their cash needs is by using stock-based compensation. During the current fiscal year, the company has paid nearly $80 million in compensation through the use of shares.

The problem is that although there are a lot of non-cash items like share-based compensation on its financials, Aurora still used up more than five times the amount of cash that it did a year ago in its day-to-day operating activities.

While that’s mainly been a result of the company’s growth, the launch of edibles and more pot shops being opened could worsen in future quarters.

Aurora has also been spending a lot on its investing activities, with $247 million being spent during the year to acquire property, plant and equipment.

Its cash burn would have been an even bigger problem if the company hadn’t gained $117 million in cash from its acquisitions. That was the main reason that the cash used from the company’s investing activities year to date was only $136 million.

The company had just $89 million on its books at the beginning of the year, and while that has increased in nine months, that’s mainly been due to loans that Aurora has taken out and, to a lesser extent, shares that it has issued.

Bottom line

Yes, Aurora has a big problem with cash burn, as do many of its peers. However, we’ve known this for some time now. The timing of the analyst’s downgrade is a bit odd and makes me wonder if it has more to do with heightened fears as a result of the CannTrust scandal.

Heading into this week, Aurora’s stock had risen more than 30% year to date, but if we factor out a very bullish January, its share price has actually fallen more than 4% since February.

The company still has a fairly strong valuation in the markets and an equity issue could certainly help alleviate concerns for the time being.

However, with more eyes now on cannabis stocks and their lack of profitability, the company is going to need to tighten up its financials.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

Farmer smiles near cannabis crop
Cannabis Stocks

Can Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4?

Down over 99% from all-time highs, Canadian pot stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets.

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »

Caution, careful
Cannabis Stocks

I Wouldn’t Touch This TSX Stock With a 60-Foot Pole

I wouldn't touch Canopy Growth Corp (TSX:WEED) stock with a 60-foot pole.

Read more »

Cannabis Stocks

Why This Little-Known Cannabis Stock Could Double in 2024

This cannabis stock has already doubled this year since 52-week lows and could easily rise that much once more.

Read more »

Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 420-Foot Pole

Down 87% from all-time highs, Cronos Group stock is a still a high-risk investment for long-term shareholders in 2024.

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth: Buy, Sell, or Hold?

Canopy Growth (TSX:WEED) stock should make a killing on U.S. expansion, but investors will need to be very patient.

Read more »